Minority enrollment on clinical trials enhances scientific rigor but requires structural changes and commitment

Healthcare Professionals for Biden

Minority enrollment on clinical trials enhances scientific rigor but requires structural changes and commitment

Dr Matt Boente shares this article from Gynecologic Oncology-online:

University of Washington School of Medicine, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology

DOI: https://doi.org/10.1016/j.ygyno.2020.04.682

A commitment to representative and equitable enrollment of marginalized populations in clinical trials is a shared value of all who are dedicated to high quality clinical research and aware of the role of health and healthcare in a just society. The known benefits of trial participation, including improved survival, are outcomes for which all communities should have equal access. Efforts to advance meaningful science are hindered by a limited understanding of social-environmental-biological interactions that are often best studied among marginalized communities where structural and environmental risks are more pronounced than in other communities.

Leave a Reply

Your email address will not be published. Required fields are marked *